Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The ...

Global Bispecific Trispecific Antibodies Market Size Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, April 04, ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing ...

SUZHOU, China, March 27, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today reported 2024 annual ...

An update from CStone Pharmaceuticals ( ($HK:2616) ) is now available. CStone Pharmaceuticals announced its participation in the AACR 2025 Annual ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

“Among these, we are excited to share updates on ZW209, our DLL3-targeting trispecific T cell engager incorporating co-stimulation, which is on track for IND submission in 1H-2026, and ZW327, our Ly6E ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

(MENAFN- GlobeNewsWire - Nasdaq) The trispecific antibody market is rapidly advancing, with 50+ candidates in clinical trials and first approvals expected by 2028. These next-gen immunotherapies ...

The trispecific antibody market has emerged as a promising and dynamic field in biopharmaceuticals, driven largely by ongoing advancements in multispecific antibody research. The success of ...

The trispecific antibody market has emerged as a promising and dynamic field in biopharmaceuticals, driven largely by ongoing advancements in multispecific antibody research. The success of monoclonal ...